On September 26, 2017, Precipio, Inc. elected each of Douglas Fisher, M.D. and Jeffrey Cossman, M.D. to the Board of Directors of the company to fill existing vacancies on the Board, each to serve until the company’s 2018 annual meeting of stockholders or his earlier resignation, retirement or removal. The Board also appointed Dr. Fisher to serve as a member of the Audit Committee and Compensation Committee of the Board and appointed Dr. Cossman to serve as a member of the Compensation Committee and the chair of the Nominating and Corporate Governance Committee of the Board. Dr. Fisher is currently an Executive in Residence at InterWest Partners LLC. Dr. Cossman is currently a medical advisor to Epigenomics AG.